Nedaplatin

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Nedaplatin
Nedaplatin.png
Systematic (IUPAC) name
Diammine[(hydroxy-κO)acetato(2-)-κO]platinum
Clinical data
AHFS/Drugs.com International Drug Names
Legal status
  • Prescription only
Routes IV
Identifiers
CAS number 95734-82-0 YesY
ATC code None
PubChem CID 6917890
UNII 8UQ3W6JXAN YesY
KEGG D01416 YesY
Chemical data
Formula C2H8N2O3Pt 
Mol. mass 303.17 g/mol
 YesY (what is this?)  (verify)

Nedaplatin (INN, marketed under the tradename Aqupla) is a platinum-based antineoplastic drug which is used for cancer chemotherapy.[1] It produces less nausea, vomiting and nephrotoxicity than other platinum-containing drugs.[2]

References[edit]

  1. ^ Wheate, Nial J.; Walker, Shonagh; Craig, Gemma E.; Oun, Rabbab (2010). "The status of platinum anticancer drugs in the clinic and in clinical trials". Dalton Transactions 39 (35): 8113–27. doi:10.1039/C0DT00292E. PMID 20593091. 
  2. ^ Ota K (February 1996). "[Nedaplatin]". Gan to Kagaku Ryoho (in Japanese) 23 (3): 379–87. PMID 8712835. 

External links[edit]